• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 PD-1(sPD-1)在人类巨噬细胞中表达。

Soluble PD-1 (sPD-1) is expressed in human macrophages.

机构信息

Department of Clinical Biochemistry, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.

Department of Clinical Biochemistry, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.

出版信息

Cell Immunol. 2021 Nov;369:104435. doi: 10.1016/j.cellimm.2021.104435. Epub 2021 Aug 29.

DOI:10.1016/j.cellimm.2021.104435
PMID:34482260
Abstract

The PD-1/PD-L1 axis plays a crucial role in regulating the anti-tumour immune response. A soluble PD-1 protein (sPD-1) has previously been observed, which could block the binding of PD-L1 to PD-1. Tumour associated macrophages are abundant in tumours, and evidence suggest they express PD-1. However, whether they also express sPD-1 remains unclear. The objective of this study was to investigate expression of sPD-1 in two in vitro models of human macrophages: THP-1 cells and monocyte-derived macrophages (MDM). Cells were polarised with either LPS + IFN-γ or IL-4 + IL-13 or left unpolarised. PD-1 and sPD-1 mRNAs were measured using droplet digital PCR, sPD-1 protein by electrochemiluminescence immunoassay and PD-1 by flow cytometry. sPD-1 mRNA was induced in both THP-1 cells and MDM after polarisation with LPS + IFN-γ, while IL-4 + IL-13 induced sPD-1 mRNA in MDM only. sPD-1 protein was measurable in culture supernatants. These findings show that macrophages can be induced to express sPD-1.

摘要

PD-1/PD-L1 轴在调节抗肿瘤免疫反应中起着至关重要的作用。先前已经观察到可溶性 PD-1 蛋白(sPD-1),它可以阻断 PD-L1 与 PD-1 的结合。肿瘤相关巨噬细胞在肿瘤中大量存在,有证据表明它们表达 PD-1。然而,它们是否也表达 sPD-1尚不清楚。本研究的目的是研究两种体外人类巨噬细胞模型:THP-1 细胞和单核细胞衍生的巨噬细胞(MDM)中 sPD-1 的表达。用 LPS+IFN-γ或 IL-4+IL-13 极化细胞,或不极化。使用液滴数字 PCR 测量 PD-1 和 sPD-1 mRNA,使用电化学发光免疫测定法测量 sPD-1 蛋白,使用流式细胞术测量 PD-1。用 LPS+IFN-γ 极化后,THP-1 细胞和 MDM 中均可诱导 sPD-1 mRNA,而 IL-4+IL-13 仅在 MDM 中诱导 sPD-1 mRNA。可在培养上清液中测量 sPD-1 蛋白。这些发现表明巨噬细胞可以被诱导表达 sPD-1。

相似文献

1
Soluble PD-1 (sPD-1) is expressed in human macrophages.可溶性 PD-1(sPD-1)在人类巨噬细胞中表达。
Cell Immunol. 2021 Nov;369:104435. doi: 10.1016/j.cellimm.2021.104435. Epub 2021 Aug 29.
2
Soluble PD-L1 improved direct ARDS by reducing monocyte-derived macrophages.可溶性 PD-L1 通过减少单核细胞衍生的巨噬细胞改善直接 ARDS。
Cell Death Dis. 2020 Oct 30;11(10):934. doi: 10.1038/s41419-020-03139-9.
3
Trophoblast-secreted soluble-PD-L1 modulates macrophage polarization and function.滋养层细胞分泌的可溶性 PD-L1 调节巨噬细胞极化和功能。
J Leukoc Biol. 2020 Sep;108(3):983-998. doi: 10.1002/JLB.1A0420-012RR. Epub 2020 May 9.
4
Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis.可溶性程序性死亡受体 1 和程序性死亡配体 2 对系统性硬化症疾病严重程度和进展的影响。
Arthritis Rheumatol. 2017 Sep;69(9):1879-1890. doi: 10.1002/art.40164. Epub 2017 Aug 1.
5
Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the PD-L1/PD-1 axis between TAMs and T lymphocytes.蛹虫草多糖通过抑制 TAMs 与 T 淋巴细胞之间的 PD-L1/PD-1 轴,将免疫抑制性巨噬细胞转化为 M1 样表型并激活 T 淋巴细胞。
Int J Biol Macromol. 2020 May 1;150:261-280. doi: 10.1016/j.ijbiomac.2020.02.050. Epub 2020 Feb 7.
6
Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer.程序性细胞死亡蛋白 1(PD-1)/程序性死亡配体 1(PD-L1)通路激活与癌症患者疼痛的关系。
Med Sci Monit. 2019 Feb 16;25:1275-1282. doi: 10.12659/MSM.912632.
7
Role of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients with cystic echinococcosis.可溶性程序性死亡因子1(sPD-1)和可溶性程序性死亡因子配体1在囊性棘球蚴病患者中的作用
Exp Ther Med. 2016 Jan;11(1):251-256. doi: 10.3892/etm.2015.2876. Epub 2015 Nov 18.
8
Analysis of the mechanisms regulating soluble PD-1 production and function in human NK cells.分析调节人 NK 细胞可溶性 PD-1 产生和功能的机制。
Front Immunol. 2023 Aug 10;14:1229341. doi: 10.3389/fimmu.2023.1229341. eCollection 2023.
9
Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells.抗原呈递过程中干扰 PD-L1/PD-1 共刺激可增强抗原特异性 T 细胞的多功能性。
Gene Ther. 2014 Mar;21(3):262-71. doi: 10.1038/gt.2013.80. Epub 2014 Jan 9.
10
[Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].[复发性阿弗他溃疡患者可溶性程序性死亡蛋白-1及可溶性程序性死亡配体-1蛋白表达与免疫状态]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2017 Jun 1;35(3):286-290. doi: 10.7518/hxkq.2017.03.011.

引用本文的文献

1
Prognostic significance of soluble PD-L1 in prostate cancer.可溶性 PD-L1 在前列腺癌中的预后意义。
Front Immunol. 2024 Jul 11;15:1401097. doi: 10.3389/fimmu.2024.1401097. eCollection 2024.
2
Analysis of the mechanisms regulating soluble PD-1 production and function in human NK cells.分析调节人 NK 细胞可溶性 PD-1 产生和功能的机制。
Front Immunol. 2023 Aug 10;14:1229341. doi: 10.3389/fimmu.2023.1229341. eCollection 2023.
3
Soluble programmed death ligand-1-induced immunosuppressive effects on chimeric antigen receptor-natural killer cells targeting Glypican-3 in hepatocellular carcinoma.
可溶性程序性死亡配体-1 对靶向肝细胞癌 Glypican-3 的嵌合抗原受体自然杀伤细胞的免疫抑制作用。
Immunology. 2023 Jun;169(2):204-218. doi: 10.1111/imm.13624. Epub 2023 Jan 25.